A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function

Clinical trial NCT04136444 · TERMINATED

Trial details

NCT number: NCT04136444
Sponsor: UCB Biopharma S.P.R.L.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Study Participants Impaired Hepatic Function

Start date: 2019-10-28
Primary completion: 2020-05-22
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.